Analysis of Clinical Predictive Factors Affecting the Outcome of Second-Line Chemotherapy for Gemcitabine-Refractory Advanced Pancreatic Cancer

BACKGROUND/AIMS: The benefit of second-line chemotherapy (SL) after failed first-line chemotherapy (FL) in patients with advanced pancreatic cancer has not yet been established. We evaluated the clinical characteristics affecting the benefits of SL compared to best supportive care (BSC), identified...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Jeung Eun, Lee, Hee Seung, Chung, Moon Jae, Park, Jeong Youp, Park, Seung Woo, Song, Si Young, Bang, Seungmin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Editorial Office of Gut and Liver 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6974334/
https://www.ncbi.nlm.nih.gov/pubmed/30974927
http://dx.doi.org/10.5009/gnl18419

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6974334/
https://www.ncbi.nlm.nih.gov/pubmed/30974927
http://dx.doi.org/10.5009/gnl18419

Ejemplares similares